| |
| |
|
| Insider
Information: |
Boess Carsten |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
125,791 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,848,912 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
125,791 |
|
|
| Total
Value |
$5,848,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Former CFO |
2005-06-27 |
5,000 |
2005-03-09 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Vice President, Intern... |
2011-04-25 |
18,941 |
2007-12-03 |
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
SVP, Chief Financial O... |
2015-06-22 |
0 |
2012-07-18 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
10% Owner |
2018-05-29 |
79,589 |
2018-05-29 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2015-02-17 |
4 |
AS |
$98.85 |
$4,234,403 |
D/D |
(42,297) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2015-02-17 |
4 |
OE |
$1.70 |
$1,206,485 |
D/D |
42,297 |
42,297 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-04-25 |
4 |
AS |
$21.54 |
$889,702 |
D/D |
(41,296) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-04-25 |
4 |
OE |
$8.04 |
$332,020 |
D/D |
41,296 |
60,237 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-29 |
4 |
AS |
$20.52 |
$726,425 |
D/D |
(35,396) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-29 |
4 |
OE |
$8.04 |
$284,584 |
D/D |
35,396 |
54,337 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-02-02 |
4 |
AS |
$17.51 |
$556,931 |
D/D |
(31,813) |
10,000 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-02-02 |
4 |
OE |
$6.83 |
$247,219 |
D/D |
31,813 |
41,813 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-24 |
4 |
AS |
$19.51 |
$612,423 |
D/D |
(31,396) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-24 |
4 |
OE |
$8.04 |
$252,424 |
D/D |
31,396 |
50,337 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-03 |
4 |
OE |
$8.04 |
$201,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,000) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2008-11-11 |
4 |
B |
$5.07 |
$117,827 |
D/D |
23,240 |
23,240 |
2.74 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2010-10-05 |
4 |
AS |
$15.03 |
$349,204 |
D/D |
(23,240) |
10,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2014-10-30 |
4 |
OE |
$1.70 |
$206,227 |
D/D |
22,904 |
22,904 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2014-10-30 |
4 |
AS |
$80.11 |
$1,834,839 |
D/D |
(22,904) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-25 |
4 |
AS |
$19.76 |
$314,256 |
D/D |
(15,900) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-25 |
4 |
OE |
$8.04 |
$127,836 |
D/D |
15,900 |
34,841 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2013-07-11 |
4 |
OE |
$1.70 |
$22,503 |
D/D |
13,237 |
13,237 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2013-07-11 |
4 |
AS |
$47.06 |
$622,933 |
D/D |
(13,237) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-30 |
4 |
OE |
$8.04 |
$95,676 |
D/D |
11,900 |
30,841 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-30 |
4 |
AS |
$20.67 |
$245,946 |
D/D |
(11,900) |
18,941 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Former CFO |
– – – |
2005-06-27 |
4/A |
OE |
$23.39 |
$263,178 |
D/D |
11,250 |
11,250 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Former Chief Financial Officer |
– – – |
2005-06-27 |
4 |
S |
$23.27 |
$263,178 |
D/D |
(11,250) |
0 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
